GMP manufacturing in the pharmaceutical industry refers to operations conducted in full compliance with Good Manufacturing Practice (GMP) guidelines. These standards ensure that medicinal products are consistently produced and controlled according to quality norms required by regulatory authorities. Eurofins BioPharma Product Testing Netherlands delivers integrated solutions covering sterile and aseptic production, QP release, and GDP distribution for pharmaceutical products, applying the principles set out in EU GMP compliance, FDA GMP regulations, and EMA GMP guidelines.
The Eurofins BioPharma Product Testing network combines manufacturing and analytical capabilities to support end‑to‑end pharmaceutical supply within a harmonised quality framework.
Why GMP compliance matters in pharmaceutical manufacturing
GMP compliance safeguards product quality, patient safety, and regulatory acceptance. Pharmaceutical products must be manufactured under controlled conditions using robust GMP quality systems, including documentation, personnel qualification, environmental monitoring, and data‑integrity controls. Regulatory authorities such as EMA and FDA assess compliance through inspections covering validation, process control, and system sustainability.
Consistent GMP compliance also enables reliable scale‑up and outsourcing of manufacturing activities from clinical development through commercial supply.
End-to-end GMP manufacturing capabilities
Eurofins BioPharma Product Testing Netherlands provides a full GMP contract manufacturing portfolio for clinical trial materials and small‑scale commercial supplies. Our core capabilities include:
- Raw‑material and consumable procurement through qualified supply chains
- Pharmaceutical compounding under validated and controlled conditions
- Sterile and aseptic GMP manufacturing, including manual Fill & Finish in Class A biosafety cabinets within Class B cleanrooms
- GMP Labelling and Packaging of pharmaceutical products, integrated or standalone
- Quality control testing and on‑site QP batch release
- GDP-compliant distribution of your pharmaceutical products
Supporting GMP-compliant pharmaceutical services
To support GMP manufacturing across the product lifecycle, Eurofins BioPharma Product Testing Netherlands also provides:
Clinical vs. commercial GMP manufacturing
While GMP principles remain consistent, manufacturing requirements vary by development stage. Clinical manufacturing emphasises flexibility for small batches and developmental adjustments, whereas commercial manufacturing requires robust change control, process validation, and supply‑continuity safeguards.
An integrated manufacturing and analytical partner supports progression from early development to commercial readiness.
Addressing compliance and manufacturing challenges
Maintaining GMP compliance across compounding, filling, validation, and release activities places significant demands on internal resources. Eurofins BioPharma Product Testing Netherlands addresses these challenges by delivering integrated GMP manufacturing, QC testing, QP release, and GDP distribution within a globally aligned quality framework, supporting regulatory confidence across clinical and commercial supply.
Why choose Eurofins BioPharma Product Testing Netherlands for you GMP Contract Manufacturing needs?
Read our flyer 'GMP Manufacturing' to learn more about our GMP Contract Manufacturing services. If you have any questions, feel free to contact us to discuss your specific GMP contract manufacturing needs.
